Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: Comparison with PET/CT, endoscopic ultrasonography, and CT

Journal of Nuclear Medicine

Volumn 55, Issue 8, 2014, Pages 1242-1247

  Lee, Geewon ^a   Hoseok, I ^a   Kim, Seong Jang ^a   Jeong, Yeon Joo ^a   Kim, In Joo ^a   Pak, Kyoungjune ^a   Park, Do Yun ^a   Kim, Gwang Ha ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Esophageal cancer; EUS; PET CT; PET MRI; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ESOPHAGEAL NEOPLASMS; PATHOLOGY; PREOPERATIVE PERIOD; PROCEDURES; RETROSPECTIVE STUDY;

AGED; DIAGNOSTIC IMAGING; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84905500880     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.114.138974     Document Type: Article

References (29)

1. Varghese TK Jr, Hofstetter WL, Rizk NP, et al. The Society of Thoracic Surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg. 2013;96:346-356.
2. Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol. 2008;14:1479-1490.
3. Rice TW. Clinical staging of esophageal carcinoma: CT, EUS, and PET. Chest Surg Clin N Am. 2000;10:471-485.
4. van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98:547-557.
5. Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versusFDG PET for presurgical detection prospective study. Radiology. 2003;227:764-770.
6. Hsu WH, Hsu PK, Wang SJ, et al. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. Ann Thorac Surg. 2009;87:1564-1568.
7. Noble F, Bailey D, Tung K, Byrne JP. Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study. Clin Radiol. 2009;64:699-705.
8. Adenaw N, Salerno M. PET/MRI: current state of the art and future potential for cardiovascular applications. J Nucl Cardiol. 2013;20:976-989.
9. Kubiessa K, Purz S, Gawlitza M, et al. Initial clinical results of simultaneous 18FFDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2014;41:639-648.
10. Rakheja R, DeMello L, Chandarana H, et al. Comparison of the accuracy of PET/CT and PET/MRI spatial registration of multiple metastatic lesions. AJR. 2013;201:1120-1123.
11. Schulz V, Torres-Espallardo I, Renisch S, et al. Automatic, three-segment, MRbased attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging. 2011;38:138-152.
12. Zaidi H, Ojha N, Morich M, et al. Design and performance evaluation of a wholebody Ingenuity TF PET-MRI system. Phys Med Biol. 2011;56:3091-3106.
13. Partovi S, Kohan A, Gaeta C, et al. Image quality assessment of automatic threesegment MR attenuation correction vs. CT attenuation correction. Am J Nucl Med Mol Imaging. 2013;3:291-299.
14. Quint LE, Glazer GM, Orringer MB. Esophageal imaging by MR and CT: study of normal anatomy and neoplasms. Radiology. 1985;156:727-731.
15. Takashima S, Takeuchi N, Shiozaki H, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR. 1991;156:297-302.
16. Riddell AM, Allum WH, Thompson JN, Wotherspoon AC, Richardson C, Brown G. The appearances of oesophageal carcinoma demonstrated on highresolution, T2-weighted MRI, with histopathological correlation. Eur Radiol. 2007;17:391-399.
17. Riddell AM, Hillier J, Brown G, et al. Potential of surface-coil MRI for staging of esophageal cancer. AJR. 2006;187:1280-1287.
18. Kayani B, Zacharakis E, Ahmed K, Hanna GB. Lymph node metastases and prognosis in oesophageal carcinoma: a systematic review. Eur J Surg Oncol. 2011;37:747-753.
19. Waterman TA, Hagen JA, Peters JH, DeMeester SR, Taylor CR, Demeester TR. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg. 2004;78:1161-1169.
20. Bruzzi JF, Munden RF, Truong MT, et al. PET/CT of esophageal cancer: its role in clinical management. Radiographics. 2007;27:1635-1652.
21. Kato H, Kimura H, Nakajima M, et al. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer. Oncol Rep. 2008;20:857-862.
22. Wallace MB, Nietert PJ, Earle C, et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/ laparoscopy. Ann Thorac Surg. 2002;74:1026-1032.
23. Yuan S, Yu Y, Chao KS, et al. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med. 2006;47:1255-1259.
24. Chakraborti KL, Jena A. MR evaluation of the mediastinal lymph nodes. Indian J Chest Dis Allied Sci. 1997;39:19-25.
25. Glazer GM, Orringer MB, Chenevert TL, et al. Mediastinal lymph nodes: relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging. Radiology. 1988;168:429-431.
26. Sundaram M, McGuire MH, Schajowicz F. Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images. AJR. 1987;148:1247-1250.
27. Lehr L, Rupp N, Siewert JR. Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging. Surgery. 1988;103:344-350.
28. Wu LF, Wang BZ, Feng JL, et al. Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI. World J Gastroenterol. 2003;9:219-224.
29. Yi CA, Shin KM, Lee KS, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-Twhole-bodyMR imaging. Radiology. 2008;248:632-642